MRP of 3 anti-cancer drugs to come down due to exemption from custom duty and reduction in GST
NPPA has issued an OM directing the concerned manufacturers to reduce the maximum retail price on Trastuzumab, Osimertinib and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
anti-cancer drugs
Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced…
Neutropenia is characterised by persistently low levels of neutrophils due to the use of chemotherapy and other types of…
Sathgen Therapeutics announces completion of first cohort in phase 1 clinical trial with anti-cancer…
Sathgen aims to develop MSP008-22 for difficult-to-treat cancers, starting with triple negative breast cancer (TNBC) and prostate…